| Affiliation: | 1. Clinical Research Division, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave. N., Mail Stop D3-100, Seattle, WA 98109, USA;2. Integrated Immunotherapy Research Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA;3. Department of Medicine, University of Washington, Seattle, WA, USA;1. Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Rosselló, 149-153, Barcelona 08036, Spain;2. Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain;3. Hematopathology Unit, Hospital Clínic of Barcelona, University of Barcelona, Villarroel 170, Barcelona 08036, Spain;1. Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medical College, 413 East 69th Street, 10021 New York, NY, USA;2. Department of Human Pathology, University of Messina,Via Consolare Valeria, 98125 Messina, Italy;3. Department of Hematology & CBMT, Ospedale di Bolzano, Via Lorenz Böhler, 5, 39100 Bolzano, Italy;4. Università della Svizzera italiana, Institute of Oncology Research, Via Vela 6, 6500 Bellinzona, Switzerland;1. Division of Hematology, The Ohio State University, 320 West 10th Avenue, A340 Starling Loving Hall, Columbus, OH 43210, USA;2. Division of Hematology, The Ohio State University, 320 West 10th Street, A350C Starling Loving Hall, Columbus, OH 43210, USA;1. Oncology Unit, Humanitas/Gavazzeni Clinic, Bergamo, Italy;2. Pathology Unit, San Raffaele Scientific Institute, Milan, Italy;3. Unit of Lymphoid Malignancies, San Raffaele Scientific Institute, Milan, Italy;4. Medical Oncology Unit, San Raffaele Scientific Institute, Milan, Italy;5. Medizinische Klinik III der Universität München–Grosshadern, München, Germany |
